Literature DB >> 2180705

Mechanisms of resistance of enterococci to beta-lactam antibiotics.

R Fontana1, P Canepari, M M Lleò, G Satta.   

Abstract

Two mechanisms are responsible for resistance of enterococci to beta-lactam antibiotics: alterations of penicillin-binding proteins and production of a beta-lactamase. The latter has been found in a few clinical isolates of Enterococcus faecalis, whereas the former appears to account for resistance in most strains. A correlation has been established between the amount of a particular penicillin-binding protein which has a low affinity for penicillin and the level of resistance. The higher activity of some penicillins, as compared to cephalosporins, has been related to the relatively higher affinity for these penicillins of the penicillin-binding protein involved in the mechanism of resistance. Alterations in the autolytic enzyme pattern have been associated with the paradoxical response to bactericidal activity of penicillin often exhibited by Enterococcus faecalis clinical isolates.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180705     DOI: 10.1007/BF01963633

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  18 in total

1.  Penicillin-binding proteins and cell shape in E. coli.

Authors:  B G Spratt; A B Pardee
Journal:  Nature       Date:  1975-04-10       Impact factor: 49.962

2.  Comparison of two beta-lactamase-producing strains of Streptococcus faecalis.

Authors:  B E Murray; D A Church; A Wanger; K Zscheck; M E Levison; M J Ingerman; E Abrutyn; B Mederski-Samoraj
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

3.  One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin.

Authors:  R Williamson; C le Bouguénec; L Gutmann; T Horaud
Journal:  J Gen Microbiol       Date:  1985-08

Review 4.  Antibiotic tolerance among clinical isolates of bacteria.

Authors:  S Handwerger; A Tomasz
Journal:  Rev Infect Dis       Date:  1985 May-Jun

5.  Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis.

Authors:  D F Sahm; C N Baker; R N Jones; C Thornsberry
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

6.  Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats.

Authors:  C Thauvin; G M Eliopoulos; S Willey; C Wennersten; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

7.  The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms.

Authors:  H EAGLE; A D MUSSELMAN
Journal:  J Exp Med       Date:  1948-07       Impact factor: 14.307

8.  Antibiotic-induced lysis of enterococci.

Authors:  G A Storch; D J Krogstad
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

9.  Streptococcus faecium ATCC 9790 penicillin-binding proteins and penicillin sensitivity are heavily influenced by growth conditions: proposal for an indirect mechanism of growth inhibition by beta-lactams.

Authors:  R Fontana; P Canepari; G Satta; J Coyette
Journal:  J Bacteriol       Date:  1983-05       Impact factor: 3.490

10.  The penicillin-binding proteins in Streptococcus faecalis ATCC 9790.

Authors:  J Coyette; J M Ghuysen; R Fontana
Journal:  Eur J Biochem       Date:  1980-09
View more
  6 in total

Review 1.  FemABX peptidyl transferases: a link between branched-chain cell wall peptide formation and beta-lactam resistance in gram-positive cocci.

Authors:  S Rohrer; B Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

2.  Mechanism of action of BAY v 3522, a new cephalosporin with unusually good activity against enterococci.

Authors:  G Amalfitano; A Grossato; R Fontana
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

3.  Pilot study of ampicillin-ceftriaxone combination for treatment of orthopedic infections due to Enterococcus faecalis.

Authors:  G Euba; J Lora-Tamayo; O Murillo; S Pedrero; J Cabo; R Verdaguer; J Ariza
Journal:  Antimicrob Agents Chemother       Date:  2009-08-10       Impact factor: 5.191

4.  Cloning and sequencing of the low-affinity penicillin-binding protein 3r-encoding gene of Enterococcus hirae S185: modular design and structural organization of the protein.

Authors:  G Piras; D Raze; A el Kharroubi; D Hastir; S Englebert; J Coyette; J M Ghuysen
Journal:  J Bacteriol       Date:  1993-05       Impact factor: 3.490

5.  Enterococcus cecorum empyema thoracis successfully treated with cefotaxime.

Authors:  Patrick C Y Woo; Dorothy M W Tam; Susanna K P Lau; Ami M Y Fung; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

6.  In vitro Antimicrobial Activity of Ampicillin-Ceftriaxone and Ampicillin-Ertapenem Combinations Against Clinical Isolates of Enterococcus faecalis with High Levels of Aminoglycoside Resistance.

Authors:  Maria Bruna Pasticci; Antonella Mencacci; Amedeo Moretti; Nicola Palladino; Luigi Maria Lapalorcia; Francesco Bistoni; Franco Baldelli
Journal:  Open Microbiol J       Date:  2008-06-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.